Verrica Pharmaceuticals logo
Verrica Pharmaceuticals
VRCA | NASDAQ
Chart Builder DCF Calculator
$3.20
-$0.36 (-10.11%)
At close: Nov 16, 2026, 4:00 PM ET
$3.48
+$0.28 (+8.75%)
Pre-market: Nov 17, 2026, 4:05 AM ET

Verrica Pharmaceuticals Cash Flow Statement

Cash flow statement explained
TTM
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-43.32M -31.18M -17.83M -17.89M -26.01M -48.6M -65.99M -76.58M -84.99M -86.93M -80.74M -67M -48.31M -23.43M -22.61M -24.49M -28.1M -41.01M -42.61M -35.08M -38.52M -36.17M -33.81M
798K 775K 767K 781K 844K 1M 1.14M 1.27M 1.23M 1.1M 974K 836K 1.01M 1.13M 1.02M 912K 717K 450K 389K 302K 170K 140K 160K
4.7M 3.51M 3.19M 3.32M 3.39M 4.78M 6.12M 7.16M 8.48M 16.04M 15.35M 14.38M 13.47M 5.22M 4.76M 4.99M 5.14M 5.2M 5.97M 6.05M 4.73M 3.25M 1.4M
9.7M 1.96M -2.76M -1.33M -5.79M -3.29M -915K -1.74M 7.77M 10.35M 11.94M 11.59M 6.17M 2.37M 376K -830K -1.11M -651K -1.26M -1.03M 7K 2.32M 802K
1.17M 6.27M 3.44M 2.41M 5.03M 4.74M 5.13M 5.19M 4.92M 4.49M 3.83M 3.35M 227K 913K 1.33M 1.74M 2.44M 1.81M 1.77M 1.8M 7.94M 8.98M 10.09M
– – – – – – – – – – – – – – – – -118K -118K -118K -118K – – –
4.58M 7.28M -3.69M -6.25M -12.35M -9.26M -48K 2.03M 10.99M -316K 6.65M 9.86M 4.58M 3.78M 596K -1.8M -2.48M -1.15M 9.47M -535K 697K 1.81M -10.93M
-32.07M -13.35M -14.11M -17.63M -29.1M -47.34M -53.66M -60.93M -59.37M -65.62M -53.93M -38.58M -29.02M -12.39M -14.9M -18.65M -22.39M -34.82M -25.14M -27.58M -24.98M -21.99M -33.09M
– – – – – -16K -27K -27K -254K -303K -351K -362K -201K -213K -308K -302K -473K -435K -577K -883K -1.19M -1.26M -1.08M
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – -8K – -4.49M -14.32M -27.18M -64.12M -68.91M -71.28M -95.82M -75.64M
– – – – – – – – – – – – 7M 9.01M 11.5M 59.01M 66.21M 83.4M 96.01M 69M 66.9M 61.09M 65.99M
– – – – – – – – – – – – -180K -34K -175K -175K -119K -265K -132K -201K -298K -298K -290K
– – – – 8K -8K -19K -19K -254K -303K -351K -362K 6.62M 8.75M 11.02M 54.04M 51.3M 55.52M 31.18M -998K -5.87M -36.28M -11.02M
-24.01M -40.23M -44.26M -48.2M -13.71M -9.96M -5.98M -2.59M -1.1M 43.24M 43.42M 44.08M 355K -87.5M -87.5M -87.5M -43.76M -6K -6K 4.97M 4.97M 4.97M 4.88M
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
-429K -429K -420K -420K 1.3M 1.3M 689K 689K -616K -616K -87K -108K 43.65M 43.65M 43.73M 43.73M -17K 28K 301K 558K 558K 513K 240K
25.63M 9.41M 5.38M 1.45M 27.23M 30.82M 34.33M 37.73M -1.73M 42.72M 43.27M 74.21M -13.26M -74.16M -74.07M -104.37M -16.87M 21K 263K 33.65M 34.09M 34.05M 33.72M
-6.44M -3.94M -9M -16.18M -1.86M -16.53M -19.34M -23.22M -61.35M -23.21M -11.01M 35.27M 51.84M 9.71M 9.55M 18.52M 12.03M 20.72M 6.31M 5.07M 3.24M -24.23M -10.39M
-32.07M -13.35M -14.11M -17.63M -29.1M -47.36M -53.68M -60.95M -59.62M -65.93M -54.29M -38.94M -29.23M -12.6M -15.21M -18.95M -22.87M -35.25M -25.71M -28.47M -26.17M -23.26M -34.17M
-36.77M -16.86M -17.3M -20.95M -32.49M -52.14M -59.8M -68.12M -68.11M -81.96M -69.64M -53.32M -42.7M -17.82M -19.97M -23.94M -28M -40.46M -31.68M -34.52M -30.91M -26.51M -35.57M
– – – – – -16K -16K -16K -16K -65K -124K -135K -142.07K -77.07K -18.07K -12.07K -242K -281K -577K -572K -403K -388K -149K
– – – – – – -11K -11K -238K -238K -227K -227K -58.93K -135.93K -289.93K -289.93K -231K -154K – -311K -787K -874K -933K
-32.07M -13.35M -14.11M -17.63M -29.1M -47.36M -53.67M -60.94M -59.39M -65.69M -54.06M -38.71M -29.17M -12.47M -14.92M -18.66M -22.64M -35.1M -25.71M -28.15M -25.39M -22.38M -33.24M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.